Addressing disparities in delivery of cancer care for patients with melanoma brain metastases-Not just a simple case of rurality.

13 However, a breakdown of survival of MBM patients treated at an academic center demonstrated an odds ratio of 1.02 which did not reach statistical significance ( P = .67), suggesting that significantly prolonged OS of patients with MBM may hinge on other factors besides access to academic centers in metropolitan locations. 13 A study of melanoma patients living in Utah reported that patients living in metropolitan counties had a 92.7% 5-year median survival compared to a 91.5% in rural counties (survival difference rate of 1.2 favoring patients in metropolitan counties), suggesting that proximity to a metropolitan area affords melanoma patients with a survival advantage.

also in 111,027 other papers